Becton Dickinson Co stock is traded at $212.78, with a volume of 1,960,694. It is up +0.05% in the last 24 hours and up +9.79% over the past month. Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Previous Close:
$212.68
Open:
$213.26
24h Volume:
1,960,694
Relative Volume:
1.04
Market Cap:
$57.96B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
53.95
EPS:
$3.94
Net Cash Flow:
$3.07B
1W Performance:
-2.41%
1M Performance:
+9.79%
6M Performance:
+44.80%
1Y Performance:
+12.24%
1-Day Range:
$211.32$216.52
1-Week Range:
$211.32$220.36
52-Week Range:
$140.11$220.36
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson CoSector
HealthcareIndustry
Medical Instruments & SuppliesPhone
(201) 847-6800Address
ONE BECTON DR, FRANKLIN LAKES, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS